Nanopublication: RAKKPbZWW2

Full identifier: http://purl.org/np/RAKKPbZWW2zCtpXkxBpobCeFrmHvkFp858NJzAW3N3ZG8

Raw formats: TriG(html,txt), JSON-LD(txt), N-Quads(txt), XML(txt)

Checking for updates...

 RAKKPbZWW2 comment approve/disapprove edit as derived nanopublication create new with same template

This is a local identifier minted within the nanopublication. http://purl.org/np/RAKKPbZWW2...#association This association http://www.w3.org/2000/01/rdf-schema#label has label (this is a literal) "rabeprazole sodium delayed release tablets is a proton pump inhibitor ppi indicated in adults for healing of erosive or ulcerative gastroesophageal reflux disease gerd 1 1 maintenance of healing of erosive or ulcerative gerd 1 2 treatment of symptomatic gerd 1 3 healing of duodenal ulcers 1 4 helicobacter pylori 1 5 treatment of pathological hypersecretory conditions including zollinger ellison syndrome 1 6 in adolescent patients 12 years of age and older for short term treatment of symptomatic gerd 1 7 rabeprazole sodium delayed release tablets is indicated for short term 4 to 8 weeks treatment in the healing and symptomatic relief of erosive or ulcerative gastroesophageal reflux disease gerd for those patients who have not healed after 8 weeks of treatment an additional 8 week course of rabeprazole sodium delayed release tablets may be considered rabeprazole sodium delayed release tablets is indicated for maintaining healing and reduction in relapse rates of heartburn symptoms in patients with erosive or ulcerative gastroesophageal reflux disease gerd maintenance controlled studies do not extend beyond 12 months rabeprazole sodium delayed release tablets is indicated for the treatment of daytime and nighttime heartburn and other symptoms associated with gerd in adults for up to 4 weeks rabeprazole sodium delayed release tablets is indicated for short term up to four weeks treatment in the healing and symptomatic relief of duodenal ulcers most patients heal within four weeks rabeprazole sodium delayed release tablets in combination with amoxicillin and clarithromycin as a three drug regimen is indicated for the treatment of patients with h pylori h pylori h pylori see clinical studies 14 5 dosage and administration 2 5 in patients who fail therapy susceptibility testing should be done if resistance to clarithromycin is demonstrated or susceptibility testing is not possible alternative antimicrobial therapy should be instituted see clinical pharmacology 12 2 clinical pharmacology 12 2 rabeprazole sodium delayed release tablets is indicated for the long term treatment of pathological hypersecretory conditions including zollinger ellison syndrome rabeprazole sodium delayed release tablets is indicated for the treatment of symptomatic gerd in adolescents 12 years of age and above for up to 8 weeks" .
This is the identifier for this whole nanopublication. http://purl.org/np/RAKKPbZWW2... This nanopublication date and time when the nanopublication was created http://purl.org/dc/terms/created was created on (this is a literal) "2021-06-14T08:19:40.943+02:00" .
This is the identifier for this whole nanopublication. http://purl.org/np/RAKKPbZWW2... This nanopublication links to the assertion template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate was created from the assertion template http://purl.org/np/RAManV5GZI... RAManV5GZI .
This is the identifier for this whole nanopublication. http://purl.org/np/RAKKPbZWW2... This nanopublication links to the provenance template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate was created from the provenance template http://purl.org/np/RANwQa4ICW... RANwQa4ICW .
This is the identifier for this whole nanopublication. http://purl.org/np/RAKKPbZWW2... This nanopublication links to the publication info template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate was created from the publication info template http://purl.org/np/RAA2MfqdBC... RAA2MfqdBC .
This is a local identifier minted within the nanopublication. http://purl.org/np/RAKKPbZWW2...#sig sig http://purl.org/nanopub/x/hasSignatureTarget has as target This is the identifier for this whole nanopublication. http://purl.org/np/RAKKPbZWW2... this nanopublication .
This is a local identifier minted within the nanopublication. http://purl.org/np/RAKKPbZWW2...#sig sig http://purl.org/nanopub/x/hasAlgorithm has the algorithm (this is a literal) "RSA" .

Leoni Bücken, 14 Jun 2021, 06:19:40 UTC

show references